Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT.

Karl, F; Liang, C; Böttcher-Loschinski, R; Stoll, A; Flamann, C; Richter, S; Lischer, C; Völkl, S; Jacobs, B; Böttcher, M; Jitschin, R; Bruns, H; Fischer, T; Holler, E; Rösler, W; Dandekar, T; Mackensen, A; Mougiakakos, D

Karl, F; Liang, C; Böttcher-Loschinski, R; Stoll, A; Flamann, C; Richter, S; Lischer, C; Völkl, S; Jacobs, B; Böttcher, M; Jitschin, R; Bruns, H; Fischer, T; Holler, E; Rösler, W; Dandekar, T; Mackensen, A; Mougiakakos, D.

Afiliação

Karl F; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Liang C; Department of Bioinformatics, University of Würzburg, Würzburg, Germany.
Böttcher-Loschinski R; Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany.
Stoll A; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Flamann C; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Richter S; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Lischer C; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Völkl S; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Jacobs B; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Böttcher M; Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany.
Jitschin R; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Bruns H; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Fischer T; Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany.
Holler E; Center for Health and Medical Prevention, Otto-von-Guericke University, Magdeburg, Germany.
Rösler W; Health Campus Immunology, Infectiology, and Inflammation, Medical Center, Otto-von-Guericke University, Magdeburg, Germany.
Dandekar T; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Mackensen A; Department of Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Mougiakakos D; Department of Bioinformatics, University of Würzburg, Würzburg, Germany.

Blood ; 141(13): 1626-1639, 2023 03 30.

Article em En | MEDLINE | ID: mdl-36564029

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Humanos; Linfócitos T; Transplante Homólogo; Doença Crônica; Recidiva; Estresse Oxidativo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google